Endothelin in nasal mucosa: Role in nasal function and inflammation

Clinical and Experimental Allergy

Volumn 30, Issue 2, 2000, Pages 172-177

  Mullol, J ^a   Picado, C ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL TONE; CILIARY MOTILITY; CYTOKINE PRODUCTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATION; NOSE SECRETION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVIEW; RHINITIS;

CYTOKINES; EICOSANOIDS; ENDOTHELINS; HUMANS; NASAL MUCOSA; NOSE; RECEPTORS, ENDOTHELIN; RHINITIS;

EID: 0033975632     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00754.x     Document Type: Review

References (54)

1. Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-5.
2. Mullol J, Baraniuk JN, Picado C, Shelhamer JH. Endothelin and the epithelium. In: Goldie RG, Hay DWP, eds. Pulmonary Actions of the Endothelins. Basel: Birkhäuser-Verlag AG, 1999:145-66.
3. Barnes PJ. Endothelins and pulmonary diseases. J Appl Physiol 1994; 77:1051-9.
4. Douglas SA, Meek TD, Ohlstein EH. Novel receptor antagonists welcome a new era in endothelin biology. Tips 1994; 15:313-6.
5. Filep JG. Endothelin peptides: biological actions and pathophysiological significance in the lung. Life Sci 1993; 52:119-33.
6. Hay DWP, Henry PJ, Goldie RG. Is endothelin-1 a mediator in asthma? Am J Respir Crit Care Med 1996; 154:1594-7.
7. Michael JR, Markewitz BA. Endothelins and the lung. Am J Respir Crit Care Med 1996; 154:555-81.
8. Inoue A, Yanagisawa M, Kimura S et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989; 86:2863-7.
9. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Tips 1992; 13:103-7.
10. MacCumber MW, Ross CA, Snyder SH. Endothelin: visualization of mRNA by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 1989; 86:7285-9.
11. Amble FR, Lindberg SO, McCaffrey TV, Runer T. Mucociliary function and endothelins 1, 2 and 3. Otolaryngol Head Neck Surg 1993; 109:634-45.
12. Casasco A, Galioto GB, Benazzo M et al. Presence of the regulatory peptide endothelin in the vascular endothelium of the human nasal mucosa. Acta Otorhinolaryngol Ital 1991; 11:185-8.
13. Mullol J, Chowdhury BA, White MV et al. Endothelin in human nasal mucosa. Am J Respir Cell Mol Biol 1993; 8:393-402.
14. Casasco A, Benazzo M, Casasco M et al. Occurrence, distribution and possible role of the regulatory peptide endothelin in the nasal mucosa. Cell Tissue Res 1993; 274:241-7.
15. Ohkubo K, Ohnishi M, Yokoshima K, Takizawa R, Okuda M, Kaliner MA. Study of endothelin: distribution in the airway and release from nasal epithelial cells. Arerugi 1994; 43:448-57.
16. Furukawa K, Saleh D, Bayan F et al. Co-expression of endothelin-1 and endothelin-converting enzyme-1 in patients with chronic rhinitis. Am J Respir Cell Mol Biol 1996; 14:248-53.
17. Gulisano M, Barni T, Fantoni G et al. Presence and location of endothelin and endothelin binding sites in human nasal mucosa under normal and metaplastic conditions. Cell Tissue Res 1998; 293:509-16.
18. Baraniuk JN, Lundgren JD, Goff J et al. Gastrin-releasing peptide in human nasal mucosa. J Clin Invest 1990; 85:998-1005.
19. Baraniuk JN, Castellino S, Lundgren JD et al. Neuropeptide Y (NPY) in human nasal mucosa. Am J Respir Cell Mol Biol 1990; 3:165-73.
20. Baraniuk JN, Lundgren JD, Goff J et al. Calcitonin generelated peptide in human nasal mucosa. Am J Physiol 1990; 258:L81-8.
21. Baraniuk JN, Lundgren JD, Okayama M et al. Vasoactive intestinal peptide in human nasal mucosa. J Clin Invest 1990; 86:825-31.
22. Ehrenreich H, Anderson RW, Fox CH et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990; 172:1741-8.
23. Mullol J, Baraniuk JN, Logun C, Picado C, Shelhamer JH. Endothelin-1 (ET-1) induces GM-CSF, IL-6 and IL-8 but not G-CSF release from a human bronchial epithelial cell line. Am J Respir Crit Care Med 1995; 151:A367.
24. Runer T, Lindberg S. Effects of endothelins 1, 2 and 3 on mucosal blood flow in the upper airways. Acta Otolaryngol (Stockh) 1996; 116:457-64.
25. Wu T, Mullol J, Rieves RD et al. Endothelin-1 stimulates eicosanoid production in cultured human nasal mucosa. Am J Respir Cell Mol Biol 1992; 6:168-74.
26. Battistini B, Sirois P, Braquet P, Filep J. Endothelin-induced constriction of guinea-pig airways: role of platelet-activating factor. Eur J Pharmacol 1990; 186:307-10.
27. Holtzman M. Arachidonic acid metabolism: implications of biological chemistry for lung function and disease. Am Rev Respir Dis 1991; 143:188-203.
28. Goodwin J. Immunomodulation by eicosanoids and anti-inflammatory drugs. Curr Opin Immunol 1989; 2:264-8.
29. Johnson CW, Rieves RD, Logun C et al. Endothelin-1 stimulates secretion of respiratory glycoprotein from human airways in vitro. Am Rev Respir Dis 1991; 143:A138.
30. Coleridge H, Coleridge J, Ginzel K, Baker D, Banzett R, Morrison M. Stimulation of irritant receptors and afferent C-fibers in the lungs by prostaglandins. Nature 1976; 264:451-3.
31. Henke D, Danilowicz R, Curtis J, Boucher R, Eling T. Metabolism of arachidonic acid by human nasal and bronchial epithelial cells. Arch Biochem Biophys 1988; 267:426-36.
32. Prat J, Mullol J, Ramis I et al. Release of chemical mediators and inflammatory cell influx during early allergic reaction in the nose. Effect of furosemide. J Allergy Clin Immunol 1993; 92:248-54.
33. Wu T, Rieves RD, Larivee P, Logun C, Lawrence MG, Shelhamer JH. Production of eicosanoids in response to endothelin-1 and identification of specific endothelin binding sites in airway epithelial cells. Am J Respir Cell Mol Biol 1993; 8:282-90.
34. Masaki T, Yanagisawa M, Takuwa Y, Yoshitoshi K, Kimura S, Goto K. Cellular mechanism of vasoconstriction induced by endothelin. In: Nishizuka Y, Endo M, Tanaka C, eds. The Biology and Medicine of Signal Transduction New York, NY: Raven Press, 1990:425-8.
35. 2 by endothelin in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 1989; 158:279-86.
36. Devalia JL, Davies RJ. Human nasal and bronchial epithelial cells in culture: an overview of their characteristics and function. Allergy Proc 1991; 12:71-9.
37. Mullol J, Baraniuk JN, Logun C, Picado C, Shelhamer JH. Endothelin-1 (ET-1) induces GM-CSF, IL-6 and IL-8 but not G-CSF release from a human bronchial epithelial cell line (BEAS-2B). Neuropeptides 1996; 30:551-6.
38. Mullol J, Xaubet A, Gayà A et al. Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy 1995; 25:607-15.
39. Xaubet A, Mullol J, López E et al. Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM-CSF and inhibition of dexamethasone. Clin Exp Allergy 1994; 24:307-17.
40. Roca-Ferrer J, Mullol J, López E et al. Effect of topical anti-inflammatory drugs on epithelial cell-induced eosinophil survival and GM-CSF secretion. Eur Respir J 1997; 10:1489-95.
41. Mullol J, López E, Roca-Ferrer J et al. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cell. Additive effects of glucocorticoids and nedocromil sodium. Clin Exp Allergy 1997; 27:1432-41.
42. Baraniuk JN, Molet S, Mullol J, Naranch K. Endothelin and the airway mucosa. Pulm Pharmacol 1998; 11:113-23.
43. Riccio MM, Reynolds CJ, Hay DWP, Proud D. Effect of intranasal administrations of endothelin-1 to allergic and non-allergic individuals. Am J Respir Crit Care Med 1995; 152:1757-64.
44. Vijayaraghavan J, Scicli AG, Carretero OA, Slaughter C, Moomaw C, Hersh LB. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem 1990; 265:14150-5.
45. Ohkubo K, Baraniuk JN, Hohman RJ et al. Human nasal mucosal neutral endopeptidase (NEP): location, quantitation, and secretion. Am J Respir Cell Mol Biol 1993; 9:557-67.
46. Ohkubo K, Baraniuk JN, Mérida M, Hausfeld JN, Okada H, Kaliner MA. Human nasal mucosa carboxypeptidase: activity, location, and release. J Allergy Clin Immunol 1998; 96:924-31.
47. Baraniuk JN, Lundgren JD, Okayama M et al. Substance P and neurokinin A in human nasal mucosa. Am J Respir Cell Mol Biol 1991; 4:228-36.
48. Matran R, Alving K, Hemsen A, Lundberg JM. Endothelin-1 increases airway mucosa blood flow in the pig. Agents Actions 1990; 31(Suppl.):237-41.
49. Auberson S, Lacroix JS, Morel DR, Lehmann W, Lundberg JM. Methylene blue attenuates vasodilation and enhances vasoconstriction in response to endothelin-1 in the pig nasal mucosa. Acta Physiol Scand 1991; 142:149-56.
50. Ichimura K, Okita W, Tanaka T. Vasoactivity of endothelin in nasal blood vessels. Rhinology 1991; 29:125-35.
51. Okita W, Ichimura K, Tanaka T, Iinuma T. The vasoactivity of endothelin in the nasal mucosa. Nip Jib Gak Ka 1991; 94:291-9.
52. Okita W, Ichimura K, Tanaka T, Iinuma T. The effect of endothelin on neurotransmitter regulation of vascular tension in the nasal mucosa. Nip Jib Gak Ka 1992; 95:187-94.
53. Benazzo M, Casasco A, Lovotti P, Icaro Cornaglia A, Casasco M, Polak JM. Endothelin-induced vasoconstriction in rabbit nasal mucosa. Acta Otolaryngol (Stockh) 1994; 114:544-6.
54. Ichimura K, Okita W, Tanaka T. Plasma endothelin-1 concentration in the inferior turbinate. J Otolaryngol 1993; 22:83-5.